U.S. FDA panel votes in favor of two anti-infective drugs
[Reuters] – A panel of advisers to the U.S. Food and Drug Administration gave favorable reviews on Monday to two new medications to treat acute bacterial skin infections. The panel voted unanimously that Cubist Pharmaceuticals Inc’s tedizolid and Durata more
View todays social media effects on CBST
View the latest stocks trending across Twitter. Click to view dashboard